Biocept Reports 2016 First Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Feltl & Co Downgrades Biocept (BIOC) to Buy
May 13, 2016 9:01 AM EDTFeltl & Co downgraded Biocept (NASDAQ: BIOC) from Strong Buy to Buy.
For an analyst ratings summary and ratings history on Biocept click here. For more ratings news on Biocept click here.
Shares of Biocept closed at $0.81 yesterday.
... MoreBiocept (BIOC) Reports Q1 Loss of $0.25/Share
May 12, 2016 4:48 PM EDTBiocept (NASDAQ: BIOC) reported Q1 EPS of ($0.25), versus ($0.37) reported last year.
For earnings history and earnings-related data on Biocept (BIOC) click here.
... More